Member Login

User ID  

International Speakers

RCPA Pathology Update 2018 Invited Guest International Guest Speakers
The Pathology Update 2018 International Guest Speakers are guests of the Royal College of Pathologists of Australasia and are presenting at the invitation of Pathology Update 2018 Overseeing Committee and Scientific Program Committees.

Any enquires about any international guest speakers is requested to go through the RCPA Events and Sponsorship Manager Eve Propper or 02 8356 5806.

Dr Volkan Adsay

Volkan Adsay

Dr Volkan Adsay completed his Anatomic Pathology and Clinical Pathology residency in New York and went on to complete a two-year fellowship in Oncologic Pathology at the Memorial Sloan-Kettering Cancer Center. After 11 years as faculty at Wayne State University and Karmanos Cancer Center, he joined Emory University in 2007. Dr Adsay is an internationally-recognised pathologist in the field of gastrointestinal and pancreatobiliary cancers. He has published over 240 peer-reviewed articles, authored several chapters in the most prestigious textbooks of diagnostic pathology (Sternberg’s Diagnostic Surgical Pathology; Odze and Goldblum’s Surgical Pathology of GI Tract, Liver, Biliary Tract and Pancreas) gastrointestinal tract surgery (Blumgart’s Surgery of the Liver, Biliary Tract and Pancreas) and oncology (Kelsen’s Gastrointestinal Tract Oncology), mostly focusing on cancers of pancreatobiliary tract, gallbladder and ampulla. He serves as President for the United States and Canadian Academy of Pathology (USCAP), President of the Pancreatobiliary Pathology Society (PBPS) and as a committee member for several national and international academic medical societies. He has given over 150 lectures for national and international platforms. He sits on the editorial board of seven medical journals including American Journal of Surgical Pathology, Virchows Archives, and Archives of Pathology and Laboratory Medicine. He is also the recipient of multiple teaching awards from medical students and residents as well as one of the recipients of the AACR Team Science Award in 2013 as a member of the Hopkins Team.

Dr Volkan Adsay will present in the Anatomical Pathology scientific stream.

Prof Patrick Bossuyt

Patrick Bossuyt

Prof Patrick Bossuyt is the Professor of Clinical Epidemiology at the University of Amsterdam. He studies the effectiveness of clinical interventions and helps translate study results to recommendations for practice.   Prof Bossuyt leads the Biomarker and Test Evaluation Research program in Amsterdam. The BiTE Program aims to appraise and develop methods for evaluating medical tests and biomarkers, and to apply these methods in relevant clinical studies. In doing so, the program wants to strengthen the evidence-base for rational decision-making about the use of tests and test strategies in health care. Prof Bossuyt spearheaded the STARD initiative for the improved reporting of diagnostic test accuracy studies. Prof Bossuyt has authored and co-authored several hundred publications in peer reviewed journals and serves on the editorial board of several of these, including Radiology and Clinical Chemistry. He chairs the Scientific Advisory Committee of the Dutch Health Insurance Board, overseeing the national health care benefits package.

Prof Patrick Bossuyt will present in the Chemical Pathology scientific stream.

Prof Christa Cobbaert

Christa Cobbaert

Prof Christa Cobbaert is a Professor of Clinical Chemistry and Laboratory Medicine at the Leiden University Medical Centre, Netherlands. Her scientific research is on medical test development and evaluation, with a major focus on standardisation, for the sake of better patient outcome. Her work has resulted in ~125 original publications and appointments to (inter)national positions because of her expertise in metrological traceability of test results. She currently develops cardiovascular protein panels using mass spectrometry-based proteomics, a promising technology for precision diagnostics and an alternative for replacing flawed and hardly standardised immunoassays. Prof Cobbaert is the current chair of the European Federation of Laboratory Medicine (EFLM) working group on Test Evaluation, which develops tools for guiding development of biomarkers to medical tests.  She is the vice-chair of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Scientific Division EC, involved with metrology and standardisation of medical tests and a member of ISO TC 212 Working Group 2 on Reference Systems.

Prof Christa Cobbaert will present in the Chemical Pathology scientific stream.

Prof Matthew Collin

Matthew Collin

Prof Matthew Collin is Professor of Haematology at Newcastle University and Director of the Northern Centre for Bone Marrow Transplantation at Newcastle upon Tyne Hospitals.  His work is dedicated to the analysis of human dendritic cells and macrophages in vivo through the Human Dendritic Cell Lab founded in 2008 at Newcastle University. His work was among the first to separate human dendritic cells and macrophages from tissues and to demonstrate the longevity and monocyte-independence of tissue macrophage populations.  With Florent Ginhoux at A*STAR Singapore, work in the Human DC Lab was instrumental in defining mouse-human parallels in the dendritic cell system including identification of the human tissue equivalent of mouse CD8+ cDC1 and mapping of the CD14+ dermal cell to a monocyte-macrophage lineage.  More recently he was among several investigators who independently identified heterozygous GATA2 mutation as the cause of a novel syndrome of mononuclear cell deficiency leading to myelodysplasia and acute myeloid leukaemia. GATA2 and IRF8 mutation have been identified as genetic causes of dendritic cell deficiency, defining a new category of human primary immunodeficiency.  His work also includes studies of histiocytosis using somatic mutation to track the clonal origin of Langerhans cell histiocytosis and Erdheim-Chester disease and exploitation of monocyte-derived cells as potential therapeutic targets in graft versus host disease.  Studies from the Human DC Lab are published in the New England Journal of Medicine, Immunity, The Journal of Experimental Medicine, Blood and the British Journal of Haematology.  Matthew is a member of the American Society of Hematology, British Society for Haematology, Fellow of the Royal College of Pathologists and Member of the Royal College of Physicians of the UK.

Prof Matthew Collin will present in the Haematology scientific stream.

A/Prof Laura Collins

Laura Collins

A/Prof Laura Collins is the Director of the Division of Anatomic Pathology at Beth Israel Deaconess Medical Center in Boston, MA and an Associate Professor of Pathology at Harvard Medical School. A/Prof Laura Collins graduated from Charing Cross and Westminster Medical School in London and completed her Anatomic and Clinical Pathology Residency Training at the Beth Israel Hospital in Boston followed by a Cytopathology Fellowship at the same institution.  She has served the United States and Canadian Academy of Pathology (USCAP) as a member of the Education Committee, Chair of the Residency Advisory Subcommittee and she is currently a member of the USCAP Board of Directors. She is the incoming President for the Arthur Purdy Stout Society of Surgical Pathologists. A/Prof Collins is an internationally renowned breast pathologist. She has published numerous original articles, review articles and book chapters on breast pathology. She was the guest editor for a monograph on Current Concepts in Breast Pathology in the Surgical Pathology Clinics series. Along with Dr Stuart Schnitt, she has published a pathology textbook entitled Biopsy Interpretation of the Breast, now in its second edition, and she was a contributor to several chapters in the WHO Classification of Tumors of the Breast, 2012.  Her research interests are in breast cancer and in particular the understanding of precursor lesions and early breast neoplasia. In addition to her work in research, A/Prof Collins is a committed educator, giving numerous lectures and post-graduate CME courses around the US and the world to support the ongoing education of pathologists and pathologists-in-training in the diagnosis of breast disease.

A/Prof Laura Collins will present in the Anatomical Pathology scientific stream.

Dr Howard Jacob

Howard Jacob

Dr Howard Jacob is a Faculty Investigator and Executive Vice President for Genomic Medicine at the HudsonAlpha Institute for Biotechnology. Dr Jacob uses molecular genetics to understand complex, multifactorial disease. His passion for improving the lives of critically ill patients has been the catalyst for his determination to bring whole genome sequencing into a clinical setting. Dr Jacob received his PhD in pharmacology from the University of Iowa in 1989. He completed two parallel postdoctoral fellowships in functional genomics and molecular genetics and genomics at Harvard, Stanford and Massachusetts Institute of Technology. He was on the faculty at Massachusetts General Hospital and Harvard Medical School before moving to the Medical College of Wisconsin (MCW) in Milwaukee. Dr Jacob was the founding director of the Human and Molecular Genetics Center as well as the Warren P. Knowles Chair of Genetics and a professor in the departments of physiology and pediatrics at MCW, positions he held for nearly 20 years. He joined the HudsonAlpha Institute for Biotechnology in 2015. In his role as Executive Vice President for Genomic Medicine at the HudsonAlpha Institute for Biotechnology, Dr Jacob leads the clinical genomics team and is heavily involved in its two clinical enterprises: the Smith Family Clinic for Genomic Medicine and the Clinical Services Lab. The Smith Family Clinic is believed to be the world's first stand-alone genomic medicine clinic devoted exclusively to the use of whole genome sequencing for the diagnosis of rare undiagnosed and misdiagnosed disease. The Clinical Services Lab offers CAP/CLIA whole genome sequencing and interpretation. Dr Jacob also runs a research lab at HudsonAlpha. His research focus is verification of specific changes to DNA that are disease causing, and pinpointing those genetic changes quickly enough to benefit patients.

Dr Howard Jacob will present in the Genetic Pathology scientific stream.

Dr Mark Lachs

Mark Lachs

Dr Mark Lachs is Director of Geriatrics for the New York Presbyterian Health System, Co-Chief of the Division of Geriatric Medicine and Gerontology at the Weill Medical College of Cornell University, and a tenured Professor of Medicine at the College. Dr Lachs’ major area of interest is the disenfranchised elderly, and he has published widely in the areas of elder abuse and neglect, financial exploitation, the measurement of functional status, and the financing of health care for an aging population. In January of 2000, Dr Lachs became the director of the Cornell Centre for Aging Research and Clinical Care (CARCC), a multidisciplinary group of scientists, clinicians, and educators who seek to speed scientific advances from bench to bedside, teach geriatric medicine to physicians-in-training at all levels, and create a trans-institutional community of gerontologists at Cornell. His service to community and country includes membership on an Institute of Medicine Committee to address the training needs of health professionals in family violence, consultation to WHO on matters related to elder abuse, and creation of the New York City Elder Abuse Center, a multidisciplinary collaboration between academicians and community partners to prevent and respond to elder abuse. He also sits on the Board of the American Federation for Aging Research where he currently serves as president.

Dr Mark Lachs will present in the combined Forensic Pathology and Clinical Forensic Medicine scientific stream.

Dr Phillip Monaghan

Phillip Monaghan

Dr Phillip Monaghan graduated from the University of Manchester Institute of Science and Technology in Biochemistry with Applied Molecular Biology, gaining his PhD in Protein Biochemistry at the University of Leicester. He obtained Fellowship of the Royal College of Pathologists in 2014. He is an Honorary Lecturer at the University of Manchester in the Faculty of Medical and Human Sciences, Institute of Inflammation and Repair, and currently a Member (YS) of the European Federation of Clinical Chemistry and Laboratory Medicine Working Group for Test Evaluation. Dr Monaghan is Deputy Chair of the Association for Clinical Biochemistry Scientific Committee’s Working Group on Traceability and Harmonisation of Calibration, UK. Special interests include test evaluation, biochemical endocrinology and assay interference. He was awarded a Research Medal from the Royal College of Pathologists in 2012 for his work on serum cortisol measurement in Cushing’s disease.

Dr Phillip Monaghan will present in the Chemical Pathology scientific program.

Dr Michele Morris

Michele Morris

Dr Michele Morris is a Professor of Clinical Medicine in the Division of Infectious Diseases at the University of Miami-Miller School of Medicine in Miami, Florida. She is Director of the Immunocompromised Host Section, providing consultation services to haematology/oncology patients and solid organ and stem cell transplant recipients at Jackson Memorial Hospital, University of Miami Hospital, and Sylvester Cancer Center.  She participates in oversight and policy development at a centre that performs over 570 solid organ transplants and 200 stem cell transplants annually. She is a Fellow of the American Society of Transplantation, the Infectious Diseases Society of America, and the American College of Physicians. She is currently President of the international Transplantation Society Transplant Infectious Diseases section. She is a member of the Mycoses Study Group, and has been a leader in the Donor Derived Infections Consensus Conferences of the American Society of Transplantation Infectious Disease Community of Practice (IDCOP). She has also been active in the Education Committee of the IDCOP, and actively participated in the IDCOP’s Influenza and Chagas Disease working groups. She served on the United Network for Organ Sharing Disease Transmission Advisory Committee, where she led the Geographic and Seasonally Endemic Infection Subcommittee, resulting in the development of infection screening guidelines for transplant candidates and living donors that have now been adopted in the United States as national policy. Her clinical research focuses on the diagnosis and management of invasive fungal and mycobacterial infections and the prevention and treatment of transplant-related infectious diseases.

Dr Michele Morris will present in the Microbiology scientific stream.

A/Prof Michelle Reid

Michelle Reid

A/Prof Michelle Reid is a board-certified cytopathologist and surgical pathologist with subspecialty sign-out responsibility in gastrointestinal, pancreatobiliary and genitourinary pathology. She has been practicing pathology for the past 11 years. She joined the faculty of the Emory University Department of Pathology in 2010 and is currently Associate Professor of Pathology and Director of Cytology Services at Emory-Midtown where over 250 EUS-guided pancreatobiliary fine needle aspiration biopsies and bile duct brushings are performed and evaluated annually. A/Prof Reid serves on several national cytopathology committees and has numerous publications on pancreatobiliary tract histopathology and cytopathology. She has led numerous courses, workshops and invited lectures on these subject areas at various national and international meetings including the College of American Pathologists (CAP), American Society for Clinical Pathology (ASCP), American Society of Cytopathology (ASC), European Congress of Pathology (ECP), International Academy of Pathology (IAP) and the upcoming United States and Canadian Academy of Pathology (USCAP) meeting. She is also Section Editor of Cytopathology for the Archives of Pathology and Laboratory Medicine journal. A/Prof Reid’s experience as both a cytopathologist and surgical pathologist with research interest in pancreatobiliary pathology give her a unique perspective on the challenges faced by pathologists who must routinely interpret these specimens, as well as the importance of accurate diagnosis of lesions involving these sites, through the identification of key discerning cyto-histomorphologic findings.

A/Prof Michelle Reid will present in the Anatomical Pathology scientific stream.

Prof Jacqueline Shaw

Jacqueline Shaw

Prof Jacqueline Shaw has been at the forefront of circulating tumour DNA research for over 15 years. Research in her team is focussed on circulating nucleic acids for early detection and monitoring of breast cancer and her group have published several first in field papers. Prof Shaw’s lab is also the cfDNA ‘hub’ for TRACERx, the major Cancer Research UK funded trial in non-small cell lung cancer. Prof Shaw leads the cfDNA advisory group for the 100,000 Genomes project led by Genomics England and serves on a number of advisory boards and editorial boards of international scientific journals.

Prof Jacqueline Shaw will present in the Genetic Pathology scientific stream.

Prof Zoltan Takats

Zoltan Takats

Prof Zoltan Takats obtained his MSc degree in Chemistry from the Eotvos Lorand University, Budapest, in 1998. He carried out his PhD research at the Chemical Research Centre of the Hungarian Academy of Sciences and at Purdue University and obtained his PhD in analytical chemistry in 2003. He has been involved in mass spectrometry-related research for more than 15 years, with a primary focus on the development of novel atmospheric pressure ionisation methods. He is the primary inventor of electrosonic spray ionisation, desorption electrospray ionisation, jet desorption ionisation and rapid evaporative ionisation mass spectrometry methods. Besides pursuing a scientific career, he has been deeply involved in the introduction of the mass spectrometry-based neonatal screening programme in Hungary and served as the head of one of the national screening laboratories. Following a couple of years spent at Justus-Liebig University in Giessen, Germany, he currently works as Professor of Analytical Chemistry at the Department of Surgery and Cancer, Faculty of Medicine, Imperial College London. Present research interests include the application of ambient ionisation methods in surgical metabonomics and development of mass spectrometric imaging techniques for the rapid phenotyping of cancer patients. 

Prof Zoltan Takats will present in the Chemical Pathology scientific stream and the Innovations Plenary.

Prof Cameron Turtle

Cameron Turtle

Prof Cameron Turtle completed medical training in Australia, followed by dual fellowships of the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia, and a PhD in Immunology. He is an Associate Member at Fred Hutchinson Cancer Research Center (FHCRC) and Associate Professor at the University of Washington (UW) in Seattle, WA. He serves as an attending physician on the Hematopoietic Stem Cell Transplant (HCT) Service and the Immunotherapy Service at FHCRC, Seattle Cancer Care Alliance (SCCA) and the UW Medical Center, and has a research laboratory in the Clinical Research Division at FHCRC. His laboratory is focused on understanding the characteristics of distinct subsets of human CD8+ T cells, their potential utility for tumour immunotherapy, and their role in immune reconstitution after HCT. Prof Turtle is Principal Investigator and IND sponsor of multiple investigator-initiated clinical trials of CD19-targeted chimeric antigen receptor (CAR)-modified T cell therapy for patients with B cell malignancies.

Prof Cameron Turtle will present in the Haematology scientific stream.

Prof Klaus Warnatz

Klaus Warnatz

Prof Klaus Warnatz completed his degree as well as his post graduate diploma (Thesis, Department of Microbiology) at the University of Aachen, Germany. He started working in 1991 at the Klinikum Rechts der Isar in Munich, followed by post-doctoral studies at the University of California at San Diego and the University of Freiburg, Germany, where he completed his habilitation in 2006. He specialised in Internal Medicine (2004) and Rheumatology and Clinical Immunology (2006). Since 2006 Prof Warnatz has been Senior Consultant in Rheumatology and Clinical Immunology, and since 2008 at the Center for Chronic Immunodeficiency, University Medical Center Freiburg, overseeing the outpatient clinic for adult immunodeficiency disorders. In 2010 he was appointed Adjunct Professor for Clinical Immunology at the Faculty of Medicine of the Albert-Ludwigs University of Freiburg, Germany. His research areas are primary and secondary immunodeficiencies in adults (common variable immunodeficiency, combined immunodeficiencies), B cell acti­va­tion and differentiation and germinal centre response in humans.

Prof Klaus Warnatz will present in the Immunopathology scientific stream.